Items where Author is "Hitz, F."

Article

Neumair, P. and Joos, L. and Warschkow, R. and Ess, S. and Hitz, F. and Frueh, M. and Brutsche, M. H. and Baty, F. and Krahenbuhl, S. and Jorger, M.. (2016) 169P: Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study. Journal of Thoracic Oncology, 11 (4 Suppl). p. 131.

Neumair, P. and Joos, L. and Warschkow, R. and Dutly, A. and Ess, S. and Hitz, F. and Fruh, M. and Brutsche, M. and Baty, F. and Krahenbuhl, S. and Cerny, T. and Joerger, M.. (2016) Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. Lung Cancer, 100. pp. 38-44.

Schuetz, P. and Kutz, A. and Grolimund, E. and Haubitz, S. and Demann, D. and Vogeli, A. and Hitz, F. and Christ-Crain, M. and Thomann, R. and Falconnier, C. and Hoess, C. and Henzen, C. and Marlowe, R. J. and Zimmerli, W. and Mueller, B. and Pro, Hosp Study Group. (2014) Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial. International Journal of Cardiology, 175 (3). pp. 464-472.

Haubitz, S. and Hitz, F. and Graedel, L. and Batschwaroff, M. and Wiemken, T. L. and Peyrani, P. and Ramirez, J. A. and Fux, C. A. and Mueller, B. and Schuetz, P.. (2014) Ruling Out Legionella in Community-acquired Pneumonia. American Journal of Medicine, 127 (10). 1010e11-9.